Loading...
XNAS
NAUT
Market cap102mUSD
Jul 09, Last price  
0.81USD
1D
2.90%
1Q
9.93%
IPO
-92.18%
Name

Nautilus Biotechnology Inc

Chart & Performance

D1W1MN
No data to show
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
77.16%
Rev. gr., 5y
%
Revenues
0k
Net income
-71m
L+11.16%
626,600,000-9,618-15,619,000-50,315,000-63,740,000-63,675,000-70,780,000
CFO
-59m
L+14.38%
-238,298,000-9,662,000-13,996,000-39,241,000-45,806,000-51,711,000-59,145,000

Profile

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
IPO date
Aug 07, 2020
Employees
153
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
81,476
81,857
67,034
Unusual Expense (Income)
NOPBT
(81,476)
(81,857)
(67,034)
NOPBT Margin
Operating Taxes
5,816
Tax Rate
NOPAT
(81,476)
(81,857)
(72,850)
Net income
(70,780)
11.16%
(63,675)
-0.10%
(63,740)
26.68%
Dividends
Dividend yield
Proceeds from repurchase of equity
524
632
794
BB yield
-0.25%
-0.17%
-0.35%
Debt
Debt current
4,097
7,076
1,991
Long-term debt
56,859
65,718
58,665
Deferred revenue
Other long-term liabilities
Net debt
(145,342)
(191,271)
(252,984)
Cash flow
Cash from operating activities
(59,145)
(51,711)
(45,806)
CAPEX
(2,122)
(2,442)
(2,324)
Cash from investing activities
66,250
(43,735)
(25,740)
Cash from financing activities
1,144
368
562
FCF
(74,586)
(88,513)
(73,556)
Balance
Cash
129,893
173,418
184,471
Long term investments
76,405
90,647
129,169
Excess cash
206,298
264,065
313,640
Stockholders' equity
(272,949)
(202,481)
(140,406)
Invested Capital
512,157
506,948
485,658
ROIC
ROCE
EV
Common stock shares outstanding
125,427
124,919
124,590
Price
1.68
-43.81%
2.99
66.11%
1.80
-65.25%
Market cap
210,717
-43.58%
373,508
66.55%
224,261
-48.74%
EV
65,375
182,237
(28,723)
EBITDA
(75,123)
(76,152)
(63,618)
EV/EBITDA
0.45
Interest
5,816
Interest/NOPBT